140 related articles for article (PubMed ID: 26270118)
21. A Meta-Analysis for Association of XRCC3 rs861539, MTHFR rs1801133, IL-6 rs1800795, IL-12B rs3212227, TNF-α rs1800629, and TLR9 rs352140 Polymorphisms with Susceptibility to Cervical Carcinoma.
Parsaeian SF; Asadian F; Karimi-Zarchi M; Setayesh S; Javaheri A; Tabatabaie RS; Dastgheib SA; Golestanpour H; Neamatzadeh H
Asian Pac J Cancer Prev; 2021 Nov; 22(11):3419-3431. PubMed ID: 34837895
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibility.
Pandey S; Mittal B; Srivastava M; Singh S; Srivastava K; Lal P; Mittal RD
Mol Biol Rep; 2011 Oct; 38(7):4715-21. PubMed ID: 21132533
[TBL] [Abstract][Full Text] [Related]
23. Possible association of Toll-like receptor 9 polymorphisms with cytokine levels and posttraumatic symptoms in individuals with various types of orthopaedic trauma: early findings.
Cohen M; Volpin G; Meir T; Klein E; Katz R; Assaf M; Pollack S
Injury; 2013 Nov; 44(11):1625-9. PubMed ID: 23953621
[TBL] [Abstract][Full Text] [Related]
24. TLR9 Rs352140 polymorphism contributes to a decreased risk of bacterial meningitis: evidence from a meta-analysis.
Xue H; Peng H; Li J; Li M; Lu S
Epidemiol Infect; 2020 Nov; 148():e294. PubMed ID: 33143777
[TBL] [Abstract][Full Text] [Related]
25. Absence of toll-like receptor 9 Pro99Leu polymorphism in cervical cancer.
Chauhan A; Pandey N; Raithatha N; Patel P; Desai A; Jain N
F1000Res; 2018; 7():606. PubMed ID: 30345020
[No Abstract] [Full Text] [Related]
26. Cytotoxic T‑lymphocyte-associated antigen‑4 polymorphisms and susceptibility to cervical cancer: a meta‑analysis.
Qiu H; Tang W; Yin P; Cheng F; Wang L
Mol Med Rep; 2013 Dec; 8(6):1785-94. PubMed ID: 24126947
[TBL] [Abstract][Full Text] [Related]
27. Association of
Zhang C; Yang Z; Luo P; Ye M; Gong P; Gong Q; Mei B
Biomark Med; 2023 Feb; 17(3):133-142. PubMed ID: 37097031
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms of Toll-like receptor 9 are associated with nasopharyngeal carcinoma susceptibility.
Dai Q; Li XP; Chai L; Long HA; Yang ZH
Tumour Biol; 2014 Apr; 35(4):3247-53. PubMed ID: 24504675
[TBL] [Abstract][Full Text] [Related]
29. Association of Toll-like receptor 3 and Toll-like receptor 9 single-nucleotide polymorphisms with hepatitis C virus persistence among Egyptians.
Hamdy S; Osman AM; Zakaria ZA; Galal I; Sobhy M; Hashem M; Allam WR; Abdel-Samiee M; Rewisha E; Waked I; Abdelwahab SF
Arch Virol; 2018 Sep; 163(9):2433-2442. PubMed ID: 29860675
[TBL] [Abstract][Full Text] [Related]
30. Impacts of CD152 polymorphisms on cervical cancer susceptibility.
Cao S; Zheng L
Pathol Res Pract; 2020 Aug; 216(8):152918. PubMed ID: 32616425
[TBL] [Abstract][Full Text] [Related]
31. Associations of toll-like receptor 4 and 2 gene polymorphisms with susceptibility to ankylosing spondylitis: A meta-analysis.
Gao S; Zhang J; Xu T; Xun C; Cao R; Guo H; Liang W; Sheng W
Int J Immunogenet; 2021 Apr; 48(2):219-228. PubMed ID: 33369094
[TBL] [Abstract][Full Text] [Related]
32. Polymorphisms and expression of toll-like receptors in autoimmune thyroid diseases.
Inoue N; Katsumata Y; Watanabe M; Ishido N; Manabe Y; Watanabe A; Masutani R; Hidaka Y; Iwatani Y
Autoimmunity; 2017 May; 50(3):182-191. PubMed ID: 28013570
[TBL] [Abstract][Full Text] [Related]
33. [The correlation between polymorphisms of Toll-like receptor 2 and Toll-like receptor 9 and susceptibility to gastric cancer].
Zeng HM; Pan KF; Zhang Y; Zhang L; Ma JL; Zhou T; Su HJ; Li WQ; Li JY; You WC
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jul; 45(7):588-92. PubMed ID: 22041559
[TBL] [Abstract][Full Text] [Related]
34. The TLR9 gene polymorphisms and the risk of cancer: evidence from a meta-analysis.
Zhang L; Qin H; Guan X; Zhang K; Liu Z
PLoS One; 2013; 8(8):e71785. PubMed ID: 23990988
[TBL] [Abstract][Full Text] [Related]
35. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.
Zhang C; Hou WH; Ding XX; Wang X; Zhao H; Han XW; Wang WJ
Asian Pac J Cancer Prev; 2016; 17(8):3785-91. PubMed ID: 27644617
[TBL] [Abstract][Full Text] [Related]
36. Gene Polymorphisms of
Tenhu E; Teräsjärvi J; Cruzeiro ML; Savonius O; Rugemalira E; Roine I; He Q; Pelkonen T
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32967147
[TBL] [Abstract][Full Text] [Related]
37. TLR4 896A/G and TLR9 1174G/A polymorphisms are associated with the risk of infectious mononucleosis.
Jabłońska A; Studzińska M; Szenborn L; Wiśniewska-Ligier M; Karlikowska-Skwarnik M; Gęsicki T; Paradowska E
Sci Rep; 2020 Aug; 10(1):13154. PubMed ID: 32753695
[TBL] [Abstract][Full Text] [Related]
38. Association of polymorphisms in Toll-like receptors 4 and 9 with risk of pulmonary tuberculosis: a meta-analysis.
Zhao L; Liu K; Kong X; Tao Z; Wang Y; Liu Y
Med Sci Monit; 2015 Apr; 21():1097-106. PubMed ID: 25889916
[TBL] [Abstract][Full Text] [Related]
39. Toll-Like Receptor 9 (TLR9) Gene C/T (rs352140) Polymorphisms in Adult Primary Immune Thrombocytopenia.
Hassan AE; Shoeib S; Abdelmohsen E; Nazir A; Dawood A; Gamal H; Abdelhafez M
Clin Appl Thromb Hemost; 2020; 26():1076029620940050. PubMed ID: 32729323
[TBL] [Abstract][Full Text] [Related]
40. Toll-like receptor 9 (TLR9) genetic variants rs187084 and rs352140 confer protection from Behcet's disease among Iranians.
Tadayon Z; Shahzadeh Fazeli SA; Gholijani N; Daryabor G
BMC Rheumatol; 2024 Mar; 8(1):13. PubMed ID: 38481344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
